Cell MedX Corp
OTC:CMXC

Watchlist Manager
Cell MedX Corp Logo
Cell MedX Corp
OTC:CMXC
Watchlist
Price: 134.435 USD -1.74%
Market Cap: 40B USD
Have any thoughts about
Cell MedX Corp?
Write Note

Cell MedX Corp
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cell MedX Corp
Total Liabilities & Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cell MedX Corp
OTC:CMXC
Total Liabilities & Equity
$46.1k
CAGR 3-Years
-4%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Liabilities & Equity
$55.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
16%
Boston Scientific Corp
NYSE:BSX
Total Liabilities & Equity
$38.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Total Liabilities & Equity
$43.8B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Liabilities & Equity
$73B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Liabilities & Equity
$17.7B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is Cell MedX Corp's Total Liabilities & Equity?
Total Liabilities & Equity
46.1k USD

Based on the financial report for May 31, 2024, Cell MedX Corp's Total Liabilities & Equity amounts to 46.1k USD.

What is Cell MedX Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-25%

Over the last year, the Total Liabilities & Equity growth was -55%. The average annual Total Liabilities & Equity growth rates for Cell MedX Corp have been -4% over the past three years , -25% over the past five years .

Back to Top